The p70 tumor necrosis factor receptor mediates cytotoxicity.

Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci U S A (1993) 3.80

The molecular biology of apoptosis. Proc Natl Acad Sci U S A (1996) 3.39

Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci U S A (1996) 3.16

Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol Cell Biol (1994) 2.90

SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor. EMBO J (2003) 2.16

Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr (2010) 1.87

Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol (1994) 1.72

Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75. J Exp Med (1995) 1.67

Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J (1999) 1.59

Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect Immun (1994) 1.57

TNF ligands and receptors--a matter of life and death. Br J Pharmacol (2002) 1.57

TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation. J Exp Med (1997) 1.56

Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase. Mol Cell Biol (2004) 1.34

Receptor-mediated choreography of life and death. J Clin Immunol (2003) 1.33

Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc Natl Acad Sci U S A (1993) 1.33

Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation. Mol Cell Biol (2000) 1.33

Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling. Cytokine (2007) 1.28

Association of a RING finger protein with the cytoplasmic domain of the human type-2 tumour necrosis factor receptor. Biochem J (1995) 1.28

The p75 nerve growth factor receptor mediates survival or death depending on the stage of sensory neuron development. Proc Natl Acad Sci U S A (1994) 1.28

Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. Am J Pathol (1993) 1.23

Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions. J Exp Med (1994) 1.23

Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am J Pathol (1995) 1.18

Dissociation of TNF-alpha cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-alpha mutants. EMBO J (1994) 1.15

Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice. Infect Immun (1998) 1.10

Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II. Mol Cell Biol (2005) 1.06

Tumor necrosis factor-α: regulation of renal function and blood pressure. Am J Physiol Renal Physiol (2013) 1.05

Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J Exp Med (1994) 1.03

Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways. Biochem J (2001) 1.00

SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus. Arthritis Res Ther (2003) 0.97

Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic mice. Proc Natl Acad Sci U S A (2003) 0.94

The pre-ligand binding assembly domain: a potential target of inhibition of tumour necrosis factor receptor function. Ann Rheum Dis (2000) 0.91

Chimeric tumor necrosis factor receptors with constitutive signaling activity. Proc Natl Acad Sci U S A (1995) 0.91

An increase in epithelial cell apoptosis is associated with chronic intestinal nematode infection. Infect Immun (2007) 0.89

A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon. J Exp Med (1996) 0.88

Analysis of p60 and p80 tumor necrosis factor-alpha receptor messenger RNA and protein in human placentas. Am J Pathol (1993) 0.87

Tight association between macrophages and adipocytes in obesity: implications for adipocyte preparation. Obesity (Silver Spring) (2013) 0.84

The role of TNF-alpha in fever: opposing actions of human and murine TNF-alpha and interactions with IL-beta in the rat. Br J Pharmacol (1996) 0.83

Isolated guinea pig gastric chief cells express tumour necrosis factor receptors coupled with the sphingomyelin pathway. Gut (1996) 0.81

Immunological markers of childhood fevers in an area of intense and perennial malaria transmission. Clin Exp Immunol (1995) 0.81

Safety evaluation and pharmacokinetics of a novel human tumor necrosis factor-alpha exhibited a higher antitumor activity and a lower systemic toxicity. Anticancer Drugs (2010) 0.80

Caffeine potentiates the lethality of tumour necrosis factor in cancer cells. Br J Cancer (1993) 0.80

Growth inhibition in clonal subpopulations of a human epithelioid sarcoma cell line by retinoic acid and tumour necrosis factor alpha. Br J Cancer (1996) 0.80

Tumour necrosis factor-induced activation of c-Jun N-terminal kinase is sensitive to caspase-dependent modulation while activation of mitogen-activated protein kinase (MAPK) or p38 MAPK is not. Biochem J (2002) 0.79

A TRAF2 binding independent region of TNFR2 is responsible for TRAF2 depletion and enhancement of cytotoxicity driven by TNFR1. Oncotarget (2014) 0.78

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis. Arthritis Res Ther (2005) 0.78

Regulation of inflammation-associated olfactory neuronal death and regeneration by the type II tumor necrosis factor receptor. Int Forum Allergy Rhinol (2013) 0.77

Colocalization of endogenous TNF with a functional intracellular splice form of human TNF receptor type 2. J Inflamm (Lond) (2005) 0.77

Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry (2008) 6.37

Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) J Clin Oncol (1999) 4.79

Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol (1996) 2.97

Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem (1996) 2.95

Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score--the CoLaus Study. Diabetologia (2009) 2.32

Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci U S A (1985) 2.16

Dynamic evolution of plant mitochondrial genomes: mobile genes and introns and highly variable mutation rates. Proc Natl Acad Sci U S A (2000) 2.13

Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res (1996) 1.97

Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study. Leukemia (2013) 1.84

Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method. Ultrasound Obstet Gynecol (2012) 1.83

Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant. J Biol Chem (1984) 1.78

Cloning of the amino-terminal and 5'-flanking region of the human MUC5AC mucin gene and transcriptional up-regulation by bacterial exoproducts. J Biol Chem (1998) 1.76

Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia. Leuk Lymphoma (2006) 1.74

An unusually small gene required for sporulation by Bacillus subtilis. Mol Microbiol (1993) 1.62

Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol (1997) 1.53

Inhibitory and anti-inflammatory effects of the Helicobacter pylori-derived antimicrobial peptide HPA3NT3 against Propionibacterium acnes in the skin. Br J Dermatol (2014) 1.43

Comparison of human immunodeficiency virus 1 DNA polymerase chain reaction and qualitative and quantitative RNA polymerase chain reaction in human immunodeficiency virus 1-exposed infants. Pediatr Infect Dis J (1999) 1.42

Intracellular gene transfer in action: dual transcription and multiple silencings of nuclear and mitochondrial cox2 genes in legumes. Proc Natl Acad Sci U S A (1999) 1.40

Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc Natl Acad Sci U S A (1993) 1.33

Identification and characterization of a human cDNA homologous to yeast SKI2. Genomics (1995) 1.27

MSX1 inhibits myoD expression in fibroblast x 10T1/2 cell hybrids. Cell (1995) 1.24

Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect. Arterioscler Thromb Vasc Biol (2001) 1.21

Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b). Br J Pharmacol (1997) 1.15

In vitro autoradiography reveals predominantly AT1 angiotensin II receptors in rat kidney. Ren Physiol Biochem (1992) 1.13

The anti-apoptotic function of human αA-crystallin is directly related to its chaperone activity. Cell Death Dis (2010) 1.11

Rb/E2F4 and Smad2/3 link survivin to TGF-beta-induced apoptosis and tumor progression. Oncogene (2008) 1.08

Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor. Proc Natl Acad Sci U S A (1990) 1.08

Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Am J Pathol (1996) 1.08

CCAAT/enhancer binding protein expression is rapidly extinguished in TA1 adipocyte cells treated with tumor necrosis factor. Mol Endocrinol (1992) 1.08

The 5-HT7 receptor: orphan found. Trends Pharmacol Sci (1997) 1.07

Comparison of systemic and mucosal vaccination: impact on intravenous and rectal SIV challenge. Mucosal Immunol (2011) 1.07

Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects. Mol Psychiatry (2012) 1.06

Stem cell transplantation for myelofibrosis: a report from two Canadian centers. Bone Marrow Transplant (2003) 1.04

Identification and characterization of a bidirectional promoter from the intergenic region between the human DDX13 and RD genes. Mol Cells (2000) 1.04

Pulmonary sequestration: angioarchitecture evaluated by three-dimensional computed tomography angiography. Thorac Cardiovasc Surg (2010) 1.03

Overexpression of and RNA interference with the CCAAT enhancer-binding protein on long-term facilitation of Aplysia sensory to motor synapses. Learn Mem (2001) 1.02

Translocation of cytosolic phospholipase A2 to the nuclear envelope elicits topographically localized phospholipid hydrolysis. Biochem J (1996) 1.01

Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55. Oncogene (2008) 1.00

Hdm2 is a ubiquitin ligase of Ku70-Akt promotes cell survival by inhibiting Hdm2-dependent Ku70 destabilization. Cell Death Differ (2009) 0.99

Human cloned alpha1A-adrenoceptor isoforms display alpha1L-adrenoceptor pharmacology in functional studies. Eur J Pharmacol (1999) 0.99

Identification and characterization of transcriptional regulatory regions associated with expression of the human apolipoprotein E gene. J Biol Chem (1988) 0.99

Cloning and functional characterization of a Caenorhabditis elegans muscarinic acetylcholine receptor. Receptors Channels (1999) 0.98

Cloning and expression of a G protein-linked acetylcholine receptor from Caenorhabditis elegans. J Neurochem (1999) 0.98

Nuclear matrix of calreticulin in hepatocellular carcinoma. Cancer Res (2000) 0.98

CBFa(AML/PEBP2)-related elements in the TGF-beta type I receptor promoter and expression with osteoblast differentiation. J Cell Biochem (1998) 0.96

Trajectory studies of S(N)2 nucleophilic substitution. 8. Central barrier dynamics for gas phase Cl(-) + CH(3)Cl. J Am Chem Soc (2001) 0.93

Blockade by intravenous losartan of AT1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography. Clin Exp Pharmacol Physiol (1994) 0.92

Immunoassay employing surface-enhanced Raman spectroscopy. Anal Biochem (1989) 0.92

The Drosophila fs(1)Ya protein, which is needed for the first mitotic division, is in the nuclear lamina and in the envelopes of cleavage nuclei, pronuclei, and nonmitotic nuclei. Dev Biol (1994) 0.91

Overamplification of macronuclear linear DNA molecules during prolonged vegetative growth of Oxytricha nova. Gene (1991) 0.91

Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies. Curr Med Res Opin (2006) 0.90

Regional localization of the putative cell surface receptor for HTLV-I to human chromosome 17q23.2-17q25.3. Virology (1995) 0.90

Disseminated trichosporonosis in China. Mycoses (2003) 0.90

Identification of a putative cellular receptor for HTLV-I by a monoclonal antibody, Mab 34-23. Virology (1993) 0.90

Amplified expression of tumor necrosis factor receptor in cells transfected with Epstein-Barr virus shuttle vector cDNA libraries. J Biol Chem (1990) 0.90

A comparison of remifentanil and fentanyl in patients undergoing surgery for intracranial mass lesions. Anesth Analg (2000) 0.88

Differential regulation of human neutrophil FcgammaRIIa (CD32) and FcgammaRIIIb (CD16)-induced Ca2+ transients. J Biol Chem (1998) 0.88

Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents. Jpn J Pharmacol (1993) 0.88

Mandibular reconstruction using computer-generated three-dimensional solid models. J Reconstr Microsurg (1994) 0.87

Regions of Byr4, a regulator of septation in fission yeast, that bind Spg1 or Cdc16 and form a two-component GTPase-activating protein with Cdc16. J Biol Chem (1999) 0.87

Angiotensin II receptor subtypes in the human central nervous system. Brain Res (1995) 0.87

Mutational analyses of fs(1)Ya, an essential, developmentally regulated, nuclear envelope protein in Drosophila. Genetics (1995) 0.87

Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks' gestation: relation to fetal and maternal characteristics and pregnancy outcomes. Fetal Diagn Ther (2013) 0.87

The cytoplasmic domain of human FcgammaRIa alters the functional properties of the FcgammaRI.gamma-chain receptor complex. J Biol Chem (1999) 0.87

Non-invasive risk assessment of fetal sex chromosome aneuploidy through directed analysis and incorporation of fetal fraction. Prenat Diagn (2014) 0.87

Assignment of a human putative RNA helicase gene, DDX3, to human X chromosome bands p11.3-->p11.23. Cytogenet Cell Genet (1998) 0.87

Byr4, a dosage-dependent regulator of cytokinesis in S. pombe, interacts with a possible small GTPase pathway including Spg1 and Cdc16. Mol Cells (1998) 0.86

The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy. Ann Rheum Dis (2007) 0.85

Autoradiographic localization of active renin in the juxtaglomerular apparatus of the dog kidney: effects of sodium intake. Clin Exp Pharmacol Physiol (1996) 0.85

Ankle-foot orthoses for preambulatory children with spastic diplegia. J Pediatr Orthop (1997) 0.85

Multivariate correlations of geochemical binding phases of heavy metals in contaminated river sediment. J Environ Sci Health A Tox Hazard Subst Environ Eng (2001) 0.84

Early passive mobilization after digital nerve repair and grafting in a fresh cadaver. Plast Reconstr Surg (2001) 0.84

European non-invasive trisomy evaluation (EU-NITE) study: a multicenter prospective cohort study for non-invasive fetal trisomy 21 testing. Prenat Diagn (2013) 0.84

Relationship between thermal parameters and tumor response in hyperthermia combined with radiation therapy. Int J Clin Oncol (2001) 0.84

Cloning and sequence analysis of the estA gene encoding enzyme for producing (R)-beta-acetylmercaptoisobutyric acid from Pseudomonas aeruginosa 1001. J Biosci Bioeng (2000) 0.83

killerFLIP: a novel lytic peptide specifically inducing cancer cell death. Cell Death Dis (2013) 0.83

AA1, a newly synthesized monovalent lipophilic cation, expresses potent in vivo antitumor activity. Cancer Res (1994) 0.83

Construction of a recombinant adeno-associated virus (rAAV) vector expressing murine interleukin-12 (IL-12). Cancer Gene Ther (2000) 0.82

Ibd1p, a possible spindle pole body associated protein, regulates nuclear division and bud separation in Saccharomyces cerevisiae. Biochim Biophys Acta (1999) 0.82

Human immunodeficiency virus type 1 (HIV-1) recombinant reverse transcriptase. Asymmetry in p66 subunits of the p66/p66 homodimer. FEBS Lett (1994) 0.82

Role of wild-type p53 in the enhancement of camptothecin cytotoxicity against human prostate tumor cells. Anticancer Res (1998) 0.82

Screening of plant extracts for human tyrosinase inhibiting effects. Int J Cosmet Sci (2012) 0.81

High resolution localization of endothelin receptors in rat renal medulla. Kidney Int (1996) 0.81

m-Calpain requires DNA for activity on nuclear proteins at low calcium concentrations. J Biol Chem (1993) 0.81

The myosin ATPase inhibitor 2,3-butanedione-2-monoxime disorganizes microtubules as well as F-actin in Saccharomyces cerevisiae. Cell Biol Toxicol (2001) 0.81

Gene structure of the human DDX3 and chromosome mapping of its related sequences. Mol Cells (2001) 0.81

Nuclear entry of the Drosophila melanogaster nuclear lamina protein YA correlates with developmentally regulated changes in its phosphorylation state. Dev Biol (1999) 0.81

Titrated propofol induction vs. continuous infusion in children undergoing magnetic resonance imaging. Acta Anaesthesiol Scand (2009) 0.80

Msh homeobox genes regulate cadherin-mediated cell adhesion and cell-cell sorting. J Cell Biochem (1998) 0.80

Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction. Chin Med J (Engl) (2001) 0.80

Modified total arch replacement using a four-branched arch graft for acute type A aortic dissection with minimal brain and spinal cord ischemic time. J Cardiovasc Surg (Torino) (2013) 0.80

Identification of a putative DEAD-box RNA helicase and a zinc-finger protein in Candida albicans by functional complementation of the S. cerevisiae rok1 mutation. Yeast (2000) 0.80

An intra-Peyer's patch gene transfer model for studying mucosal tolerance: distinct roles of B7 and IL-12 in mucosal T cell tolerance. J Immunol (2000) 0.80

Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice. Life Sci (1996) 0.79

Loss of E-cadherin in multidrug resistant breast cancer cell line MCF-7/Adr: possible implication in the enhanced invasive ability. Eur Rev Med Pharmacol Sci (2012) 0.79

Double stapling method of anastomosis after esophagectomy with endoscopic stapler to prevent postoperative stricture. J Laparoendosc Adv Surg Tech A (1998) 0.79

Multiple pathways of angiotensin I conversion and their functional role in the canine penile corpus cavernosum. J Pharmacol Exp Ther (2001) 0.78

An active recombinant p15 RNase H domain is functionally distinct from the RNase H domain associated with human immunodeficiency virus type 1 reverse transcriptase. J Biol Chem (1994) 0.78

Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma. Bone Marrow Transplant (2002) 0.78